You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lobular Carcinoma in Situ

Showing 1 - 25 of 9,531
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

Recruiting
  • Pleomorphic Lobular Breast Carcinoma in Situ
  • Breast Florid Lobular Carcinoma in Situ
  • Surgical wide local excision
  • +4 more
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Nov 14, 2023

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Searching for Novel Germline Mutations in Lobular Breast Cancer

Recruiting
  • Lobular Breast Carcinoma
  • +3 more
  • Illumina panel
  • Milan, Italy
    European Institute of Oncology
Sep 12, 2022

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Standard Breast Cancer Risk Assessment for African American and

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 22, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in

Recruiting
  • Atypical Hyperplasia of the Breast
  • +2 more
  • Cancer Educational Materials
  • +3 more
  • Costa Mesa, California
  • +48 more
Jan 9, 2023

Molecular Genetic Basis of Invasive Breast Cancer Risk

Completed
  • Breast Cancer
  • +2 more
  • Tissue specimen
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 30, 2021

Treating Patients With Stage IV Breast Cancer

Active, not recruiting
  • Central Nervous System Metastases
  • +15 more
  • hyperfractionated radiation therapy
  • +2 more
  • North Chicago, Illinois
    University of Chicago
Dec 6, 2021

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ Trial in Boston (Naltrexone, Sugar

Terminated
Has Results
  • Invasive Breast Cancer (Stage I-III)
  • +4 more
  • Boston, Massachusetts
  • +1 more
Nov 12, 2021

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Follow-Up
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 16, 2021

Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ Trial in Columbus (EMBr Wave, Questionnaire

Recruiting
  • Breast Carcinoma
  • +3 more
  • EMBr Wave
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 20, 2021

Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,

Completed
  • Breast Cancer Female
  • +6 more
  • Breast reconstruction decision aid
  • Educational website
  • Austin, Texas
    Texas Oncology
Nov 1, 2021

Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • +12 more
  • Endoxifen Hydrochloride
  • +2 more
  • Los Angeles, California
  • +2 more
Mar 8, 2022

Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston

Completed
Has Results
  • Benign Breast Neoplasm
  • +11 more
  • Docosahexaenoic Acid
  • Placebo
  • Boston, Massachusetts
  • +3 more
Dec 3, 2021

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

DCIS Grade 3, Stage I Breast Cancer, Stage II Breast Cancer Trial in Oslo, Trondheim (Intervention. Exercise)

Active, not recruiting
  • DCIS Grade 3
  • +3 more
  • Intervention. Exercise
  • Oslo, Norway
  • +1 more
Apr 23, 2021

Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lobular Breast Carcinoma
  • Blood Specimen
  • San Francisco, California
    University of California, San Francisco
Jul 19, 2023

Lobular Breast Carcinoma Trial in Monaco (68Ga-FAPI-46 PET scan)

Not yet recruiting
  • Lobular Breast Carcinoma
  • 68Ga-FAPI-46 PET scan
  • Monaco, Monaco
    Centre Hospitalier Princesse Grace
Jun 27, 2023

Carcinoma, Lobular Trial ([18F]fluoroestradiol (FES))

Not yet recruiting
  • Carcinoma, Lobular
  • [18F]fluoroestradiol (FES)
  • (no location specified)
Jul 18, 2023

Invasive Ductal and Invasive Lobular Breast Carcinoma, Stage 0 Breast Carcinoma, Stage I Breast Carcinoma Trial in Orange

Active, not recruiting
  • Invasive Ductal and Invasive Lobular Breast Carcinoma
  • +3 more
  • Intraoperative Radiotherapy
  • Orange, California
    St. Joseph Hospital of Orange
Mar 30, 2021

CDH1 Germline Mutations in Lobular Breast Cancer

Active, not recruiting
  • Lobular Breast Carcinoma
  • CDH1 Gene Inactivation
    • Milan, Italy
      European Institute of Oncology
    Jan 11, 2022